Skip to main content
. 2022 Dec 21;3(1):4. doi: 10.3892/mi.2022.64

Table I.

Spearman's correlation analysis for the correlation between the serum TSTD2 antibody levels and clinical features of patients with aCI.

Variables Spearman's rank correlation coefficient (Rho) P-value
Age, years 0.0954 0.0624
BMI 0.0193 0.7075
Maximum IMT 0.1703 0.0028
AST 0.0054 0.9161
ALT -0.0428 0.4051
ALP 0.0647 0.228
LDH 0.086 0.0986
tBil -0.0226 0.6642
CHE -0.1960 0.0009
γ-GTP 0.0586 0.2677
TP -0.0910 0.0797
ALB -0.1727 0.0007
BUN 0.034 0.5082
Creatinine -0.0079 0.8783
eGFR -0.0124 0.8154
UA 0.069 0.2558
AMY -0.0764 0.2537
T-CHO -0.1567 0.0046
HDL-C -0.0673 0.3106
TG -0.1109 0.0814
Na -0.0139 0.7877
K -0.0994 0.054
Cl -0.0989 0.055
CRP 0.1395 0.0221
WBC 0.0905 0.0783
RBC -0.0673 0.1912
HGB -0.0564 0.2737
HCT -0.0626 0.2243
PLT -0.0481 0.3503
BS 0.1542 0.0039
HbA1c -0.0250 0.6695
Smoking duration (years) 0.1938 0.0002
Frequency of alcohol consumption (times/week) 0.1174 0.0241

A correlation analysis was performed to identify the correlation between TSTD2 antibody levels and the clinical features of patients with ischemic stroke. Correlation coefficients (Rho) and P-values were calculated using Spearman's correlation analysis. Significant correlations (P<0.05) are marked in bold font. aCI, acute cerebral infarction; TSTD2, thiosulfate sulfurtransferase-like domain-containing 2; BMI, body mass index; IMT, intima-media thickness; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; tBil, total bilirubin; CHE, choline esterase; γ-GTP, γ-glutamyl transpeptidase; TP, total protein; ALB, albumin; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; UA, uric acid; AMY, amylase; T-CHO, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; CRP, C-reactive protein; WBC, white blood cell count; RBC, red blood cell count; HCT, hematocrit; PLT, platelet count; BS, blood sugar; HbA1c, hemoglobin A1c.